TCTMD

Societies Issue Three-Part Compendium on Female Heart Health

Pulmonary embolism may have a connection with atherosclerotic cardiovascular disease—a recent analysis of US data shows that PE-attributed deaths are on the rise among ASCVD patients, especially for younger adults and racial/ethnic minority groups. https://bit.ly/4e0H4wZ

New evidence suggests that blood-pressure drops during stroke thrombectomy are associated with worse functional recovery. The findings highlight a critical consideration for teams treating large-vessel occlusion stroke. https://bit.ly/47opdfP

🔥 Four days to go! The conversations, discoveries, and innovations that will drive cardiovascular care forward are just around the corner. Be part of the experience everyone will be talking about. 👉 Register for #TCT2026! https://ow.ly/XpTi50ZXmMA #interventionalcardiology #cardiosky

Cardiologists Grapple With AI-Generated Content in Slides

Edwards Lifesciences has pulled certain lots of its Sapien M3 delivery system following reports of balloons bursting during TMVR. The issue has been associated with one death and one serious injury, according to an FDA early alert. https://bit.ly/4k0MsUs

What’s Going to Be Hot at AHA 2026

A potential new role for SGLT2 inhibitors in ANOCA? Empagliflozin was associated with improved angina for these patients in a small pilot study and might even help reverse endothelial dysfunction, though experts caution that the findings are preliminary. https://bit.ly/4ySBapY

Experts at #VIVA2026 emphasized the need to shift from reactive treatment to earlier detection and prevention, pointing to AI, targeted screening, and policy changes as potential avenues to improve vascular care and limb preservation. https://bit.ly/4sbdPNR

Early Signs of Vascular, Cardiorespiratory Problems Seen in Regular Vape Users

October 2026 Dispatch for the CV Team

On-Duty Firefighter Deaths Are Increasingly Cardiac in Nature

New observational data suggest that PCI within 24 hours may be associated with worse outcomes than a delayed approach, highlighting the opportunity to pause, optimize medical therapy, and then make a decision about revascularization. https://bit.ly/4jnbAEW

What does it mean to leave cardiac care better for the next generation? In TCTMD’s Hearts & Minds podcast, John D. Puskas joins Yael Maxwell for a conversation about the values that guide his work and the drive to keep advancing the field. Listen to the full episode: https://bit.ly/4sjiEoh

‘Teleprehabilitation’ Likely Cost-effective Before Cardiac Surgery

US Data Support Link Between Pulmonary Embolism, ASCVD

⏳ Short on time? You don't have to miss out on the world's premier forum in interventional cardiovascular medicine. ✨ Choose the day that fits your schedule and experience the science, innovation, and leaders shaping the future of care! https://ow.ly/H28s50ZYCza #cardiosky

The Viabahn VBX, sold in the US for nearly a decade, is now the first and only FDA-approved bridging stent graft for use in FEVAR and BEVAR. https://bit.ly/47j2BgE

Quitting Anabolic-Androgenic Steroids Can Reverse Some Adverse Cardiac Effects

FDA Green-lights Pascal System for Tricuspid Valve Repair

Surgeon, researcher, inventor, and educator John Puskas joins @yaelmaxwell.bsky.social in the latest episode of TCTMD’s Hearts & Minds podcast for a conversation about advances in surgical coronary revascularization. Listen to the full episode: https://bit.ly/486dOkS

10. John Puskas on Creativity and Iteration

Heart failure care has advanced, but the US burden continues to grow. A new report shows mortality is rising as more Americans are being affected, with obesity, diabetes, and other comorbidities potentially contributing to the trend. #HeartFailure #PublicHealth https://bit.ly/4rZGy8a

Let's play a little game. A new episode of TCTMD's Hearts & Minds podcast is dropping tomorrow. Who do you think sat down with host @yaelmaxwell.bsky.social for this month's conversation?

What’s on the horizon at TCT 2026? From 28 late-breaking studies to hands-on training and AI’s expanding role in cardiology, Caitlin E. Cox previews the science and sessions to watch in San Diego. https://bit.ly/4sfyWhV

Upcoming EuroSCORE Update Highlights Current Model’s Drawbacks

For patients with prior CABG but no MI, the cardiovascular benefits of evolocumab hold up in a VESALIUS-CV analysis. The findings should encourage surgeons to take a more active role in lipid management after patients leave the OR. https://bit.ly/4s76uip

Intraoperative Hypotension Tied to Worse Outcomes After Stroke Thrombectomy

What’s Going to Be Hot at TCT 2026

ELEGANCE Registry: High Patency With DES in Diverse PAD Patients

For rural patients with AAA who undergo EVAR, new US registry data show that care gaps exist for screening, treatment, and follow-up. Researchers say a community-level approach to change may help. https://bit.ly/4zqOZvA

Even among operators new to the procedure, deep-vein arterialization in "no-option" CLTI patients improved pain, with amputation-free survival of 76.3% at 1 year in PROMISE III.https://bit.ly/4esxVxf

Science, networking, and beyond: With #TCT2026 approaching, Fellow Talk blogger Shikha Jha shares seven things you can look forward to at this year’s meeting. #FellowsForum https://bit.ly/4igrSy7

As Years Pass, Mortality Grows Higher With TAVI vs SAVR in Low-risk Patients: Meta-analysis

Edwards Pulls Some Lots of Sapien M3 Delivery System: FDA Alert

SGLT2 Inhibition Promising in ANOCA Patients With Microvascular Dysfunction

Two novel incretin-based agents appear highly effective in type 2 diabetes, with the TRIUMPH-2 and SYNCHRONIZE-2 studies of #retatrutide and #survodutide, respectively, showing reductions in body weight and better glycemic control. https://bit.ly/4yQK8Ef

Screening, Legislation, and AI May Help Close Gaps in PAD Care

Heading to AHA in Chicago? Roxana Mehran and Joanna Chikwe preview the research, discussions, and in-person connections to expect at the meeting. Listen to the full #RoxHeartRadio podcast, then follow TCTMD’s #AHA coverage for the latest updates from Chicago. https://bit.ly/47V8wbR

Early PCI Tied to Worse Outcomes in NSTEMI Patients With Stable HF

Can routine cerebral embolic protection lower stroke risk in #TAVI? Rajesh Kharbanda and C. Michael Gibson explore the evidence. Listen to the full #TalkingPoints podcast on TCTMD or SoundCloud for the complete discussion. https://bit.ly/47SPpiC

Viabahn VBX Stent Graft Gains FDA-Approved Indications in Complex Aortic Disease

When is hemodynamic support appropriate for high-risk PCI? Dr. Sanjog Kalra talks patient selection, revascularization strategies, and practical considerations through real-world cases. https://www.tctmd.com/putting-high-risk-pci-patients-first-applying-hemodynamic-support-evidence-in-practice

New registry data presented at #EACTS2026 suggest the survival benefit favoring #TAVI over #SAVR in DEDICATE-DZHK6 may be less pronounced outside the trial setting. https://bit.ly/4hNlcaR

Rox Heart Radio: AHA 2026 Approaches

The BHF PROTECT-TAVI Trial

At VIVA 2026, researchers reported promising findings for two bioresorbable, limus-eluting scaffolds—Espirit BTK and Motiv—in below-the-knee infrapopliteal disease and chronic limb-threatening ischemia. https://bit.ly/47Oq1dP

Amiodarone Patch Doesn’t Prevent Postoperative AF After Cardiac Surgery: BEAT-AF

US Heart Failure Landscape Continues to Worsen: HF STATS 2026

As Hispanic Heritage Month comes to a close, Johanna Contreras shares her #QuickTakes on the disproportionate burden of disease faced by Hispanic and Latino adults in the US, as stated recently by @americanheart.bsky.social. https://bit.ly/4jSmwKD